CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 44 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,739 | +10.9% | 2,000 | +42.9% | 0.00% | – |
| Q2 2023 | $1,568 | -81.0% | 1,400 | -82.4% | 0.00% | – |
| Q1 2023 | $8,268 | -24.8% | 7,950 | -20.1% | 0.00% | – |
| Q4 2022 | $11,000 | 0.0% | 9,950 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | -38.9% | 9,950 | -19.4% | 0.00% | – |
| Q2 2022 | $18,000 | -35.7% | 12,350 | 0.0% | 0.00% | – |
| Q1 2022 | $28,000 | -17.6% | 12,350 | 0.0% | 0.00% | – |
| Q4 2021 | $34,000 | -39.3% | 12,350 | +32.1% | 0.00% | – |
| Q3 2021 | $56,000 | +55.6% | 9,350 | +26.4% | 0.00% | – |
| Q2 2021 | $36,000 | +500.0% | 7,400 | +208.3% | 0.00% | – |
| Q1 2021 | $6,000 | -14.3% | 2,400 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | +75.0% | 2,400 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -20.0% | 2,400 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 2,400 | -9.4% | 0.00% | – |
| Q1 2020 | $4,000 | – | 2,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |